Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10518 in Chinese Women Undergoing ART COS (Phase II)
CTR20254605Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of merigolix in infertility, sponsored by Hengrui Therapeutics. Started Jan 2026; status: active.
02
Drugs
merigolix
03
Conditions
infertility
Beyond the preview
Go deeper on CTR20254605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254605.